Haemonetics (HAE) Market Capitalization (2009 - 2026)

Haemonetics has reported Market Capitalization for 18 years, with the latest figure at $3.5 billion in Q2 2026.

• On a quarterly basis, Market Capitalization fell 1.12% year-over-year to $3.5 billion in Q2 2026; TTM through Jun 2026 was $3.5 billion, a 1.12% decrease from a year earlier, with the FY2026 full-year figure at $2.4 billion, down 19.74% from the prior year.
• Market Capitalization was $3.5 billion for Q2 2026 at Haemonetics, up from $2.4 billion in the prior quarter.
• The five-year high for Market Capitalization was $4.5 billion in Q3 2023, with the low at $2.3 billion in Q3 2025.
• Average Market Capitalization over 5 years is $3.7 billion, with a median of $3.8 billion recorded in 2025.
• The largest YoY upside for Market Capitalization was 46.35% in 2022 against a maximum downside of 55.08% in 2022.
• Over 5 years, Market Capitalization stood at $4.0 billion in 2022, then gained by 9.46% to $4.3 billion in 2023, then decreased by 10.27% to $3.9 billion in 2024, then declined by 3.52% to $3.8 billion in 2025, then declined by 6.52% to $3.5 billion in 2026.
• The last three Market Capitalization figures came in at $3.5 billion (Q2 2026), $2.4 billion (Q1 2026), and $3.8 billion (Q4 2025), per Business Quant data.